This HTML5 document contains 122 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
n12http://dx.doi.org/10.1158/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38127164
rdf:type
wikibase:Item
schema:description
wissenschaftlicher Artikel научная статья vitskapeleg artikkel artigo científico artikel ilmiah vědecký článek научни чланак article scientifique articolo scientifico scienca artikolo vedecký článok videnskabelig artikel artículo científico artigo científico מאמר מדעי artículu científicu espublizáu en 2013 scientific article published on 06 August 2013 bilimsel makale scientific article published on 06 August 2013 artikull shkencor articol științific wetenschappelijk artikel article científic наукова стаття, опублікована в серпні 2013 vetenskaplig artikel বৈজ্ঞানিক নিবন্ধ artigo científico vitenskapelig artikkel مقالة علمية نشرت في 06 أغسطس 2013 scientific article published on 06 August 2013
p:P577
wds:Q38127164-34466FB5-C30D-440B-BA10-2B88FE86230D
wdt:P577
2013-08-06T00:00:00Z
p:P407
wds:Q38127164-89A1212F-1F5D-4990-BDF8-9248C7EF4580
wdt:P407
wd:Q1860
p:P2093
wds:Q38127164-097BE618-AC7E-4852-9BB9-F17C884A006C wds:Q38127164-0BEE756A-91F2-456D-B66F-3646852F9C67 wds:Q38127164-00B34ABA-385A-4BF1-A00A-6602F4B37EA1 wds:Q38127164-EE3BA3D6-18FB-469B-95B5-C024B50121A2 wds:Q38127164-E00762E9-8CB1-4F08-958B-1D6254FD4EA7 wds:Q38127164-C15FDD6B-772F-40E4-AA7A-9633E084BB69 wds:Q38127164-95E5773E-4CD1-4EDC-B55B-C594263369BA wds:Q38127164-92EAD9A2-AE53-4E10-8756-51B52BA026FB wds:Q38127164-93F68097-798A-4DEB-8AEE-80787D655B39 wds:Q38127164-226E7F79-08F0-4CF6-AA4D-B699F169ACAA wds:Q38127164-21A6E07E-36D8-4BA2-9E81-D78666610987 wds:Q38127164-224B23F0-37AF-4C1B-B6C3-A0B892670ED0 wds:Q38127164-1CB926DB-5880-413C-9569-140A4642DEE3
wdt:P2093
Amit M Oza Bella Kaufman Vincent Castonguay Timothy A Yap Lee-May Chen Stan B Kaye Hilda High Michael L Friedlander Charlie Gourley Tina Atkinson C Bethan Powell Joo Ern Ang Lina Chen
rdfs:label
Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study
skos:prefLabel
Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study
schema:name
Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study
p:P50
wds:Q38127164-BE4D5A8C-B45F-4FEF-B4FC-AC939F79EE28 wds:Q38127164-CC40F9D4-E985-49A7-B7D5-657A433A6B81 wds:Q38127164-DA7F23A5-E408-4B99-A2B5-CA882037D465 wds:Q38127164-FB546327-5750-4E1A-90EF-2056FB1D9DBA wds:Q38127164-FFB0E35C-3EAE-498D-83CE-A6E1CBBCC62F wds:Q38127164-DEC0B698-9D74-4461-8A33-AD0880F64403 wds:Q38127164-479F8079-90B8-495B-BB0F-915B5419E4EA wds:Q38127164-3F20D60E-074A-41C6-87B3-CE7DF5F7EB2E wds:Q38127164-74AE0BF1-8D0D-4591-BEE7-DD8E59FDD946 wds:Q38127164-76C44F23-817C-4608-9767-B08BF90E3E34 wds:Q38127164-7DCDE230-105E-4F98-802F-91C78252FAC7 wds:Q38127164-5934A0B4-BADF-4C11-B9F6-2F0B5E7B5DF6 wds:Q38127164-0CC36CEE-DAEA-4676-BD59-BD32C92E8C55 wds:Q38127164-0F11217D-6DE6-4E02-91FB-2C17A8F5F3DF
wdt:P50
wd:Q60042780 wd:Q37392895 wd:Q58132858 wd:Q57334442 wd:Q43249916 wd:Q116996864 wd:Q4706084 wd:Q114430417 wd:Q98180996 wd:Q42860178 wd:Q114430415 wd:Q114430416 wd:Q104281949 wd:Q90408920
p:P1476
wds:Q38127164-EB451868-9668-4909-A25D-BA7F71CEFD08
wdt:P1476
Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study
p:P304
wds:Q38127164-4F70FA2E-D893-4912-A5A0-DB67C1E57868
wdt:P304
5485-5493
p:P31
wds:Q38127164-725D445D-C808-40F3-AAC4-34B6A90EC891
wdt:P31
wd:Q13442814
p:P921
wds:Q38127164-475D17CE-090E-49F2-8046-6D98ADAF6CBF wds:Q38127164-4B275043-DF24-40CB-9B00-E63B99EC7F94 wds:Q38127164-27BD59DA-81D7-41C7-BF98-6C2A409B946C
wdt:P921
wd:Q28444960 wd:Q974135 wd:Q172341
p:P698
wds:Q38127164-6C1EE79F-944E-4A10-AAB6-6D5D62E206D6
wdtn:P698
n8:23922302
wdt:P698
23922302
p:P1433
wds:Q38127164-130CEDA1-C676-4BF0-9024-80B1D1274995
wdt:P1433
wd:Q332253
p:P433
wds:Q38127164-98BCDBAF-B07C-4FEA-B3CF-6C625749AF44
p:P478
wds:Q38127164-6C2FAEEC-0DCF-484A-868B-D039C60C5D0B
wdt:P433
19
wdt:P478
19
p:P356
wds:Q38127164-DB62B942-6398-4B7A-B0E7-49BE6B916B75
wdtn:P356
n12:1078-0432.CCR-13-1262
wdt:P356
10.1158/1078-0432.CCR-13-1262